These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

81 related items for PubMed ID: 2453268

  • 1. Increased growth inhibition and DNA lesions in human colon adenocarcinoma cells treated with methotrexate or 5-fluorodeoxyuridine followed by calmodulin inhibitors.
    Lönn U, Lönn S.
    Cancer Res; 1988 Jun 15; 48(12):3319-23. PubMed ID: 2453268
    [Abstract] [Full Text] [Related]

  • 2. Increased levels of DNA lesions induced by leucovorin-5-fluoropyrimidine in human colon adenocarcinoma.
    Lönn U, Lönn S.
    Cancer Res; 1988 Aug 01; 48(15):4153-7. PubMed ID: 2968838
    [Abstract] [Full Text] [Related]

  • 3. 5-Fluoropyrimidine-induced DNA damage in human colon adenocarcinoma and its augmentation by the nucleoside transport inhibitor dipyridamole.
    Lönn U, Lönn S, Nylen U, Winblad G.
    Cancer Res; 1989 Mar 01; 49(5):1085-9. PubMed ID: 2521812
    [Abstract] [Full Text] [Related]

  • 4. Loss of alpha 2-macroglobulin and epidermal growth factor surface binding induced by phenothiazines and naphthalene sulfonamides.
    DiPaola M, Keith CH, Feldman D, Tycko B, Maxfield FR.
    J Cell Physiol; 1984 Feb 01; 118(2):193-202. PubMed ID: 6319437
    [Abstract] [Full Text] [Related]

  • 5. DNA lesions in human neoplastic cells and cytotoxicity of 5-fluoropyrimidines.
    Lönn U, Lönn S.
    Cancer Res; 1986 Aug 01; 46(8):3866-70. PubMed ID: 2942236
    [Abstract] [Full Text] [Related]

  • 6. Potentiation of sensitivity to bleomycin and the drug-induced DNA damage in EMT6 cells by the calmodulin inhibitor trifluoperazine.
    Smith PJ, Mircheva JJ, Bleehen NM.
    Acta Physiol Pharmacol Bulg; 1987 Aug 01; 13(1):41-5. PubMed ID: 2441572
    [Abstract] [Full Text] [Related]

  • 7. Potentiation of DNA damage and cytotoxicity by calmodulin antagonists.
    Rosenthal SA, Hait WN.
    Yale J Biol Med; 1988 Aug 01; 61(1):39-49. PubMed ID: 2452522
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Lidocaine potentiation of bleomycin A2 cytotoxicity and DNA strand breakage in L1210 and human A-253 cells.
    Lazo JS, Braun ID, Meandzija B, Kennedy KA, Pham ET, Smaldone LF.
    Cancer Res; 1985 May 01; 45(5):2103-9. PubMed ID: 2580616
    [Abstract] [Full Text] [Related]

  • 10. Apoptosis primarily accounts for the growth-inhibitory properties of sulindac metabolites and involves a mechanism that is independent of cyclooxygenase inhibition, cell cycle arrest, and p53 induction.
    Piazza GA, Rahm AK, Finn TS, Fryer BH, Li H, Stoumen AL, Pamukcu R, Ahnen DJ.
    Cancer Res; 1997 Jun 15; 57(12):2452-9. PubMed ID: 9192825
    [Abstract] [Full Text] [Related]

  • 11. Drug-induced DNA hypermethylation and drug resistance in human tumors.
    Nyce J.
    Cancer Res; 1989 Nov 01; 49(21):5829-36. PubMed ID: 2790794
    [Abstract] [Full Text] [Related]

  • 12. Differential effect of 9 beta-chloro-16, 16-dimethyl prostaglandin E2 (nocloprost) on the radiation response of human normal fibroblasts and colon adenocarcinoma cells.
    Zaffaroni N, Villa R, Orlandi L, De Pascale A, Del Mastro S, Silvestrini R.
    Radiat Res; 1993 Jul 01; 135(1):88-92. PubMed ID: 8327666
    [Abstract] [Full Text] [Related]

  • 13. [The effect of calmodulin antagonist on the anticancer effect of vinblastine].
    Liu SR, Zhang Y, Lu HM.
    Zhonghua Yi Xue Za Zhi; 1994 Nov 01; 74(11):680-2, 710. PubMed ID: 7866904
    [Abstract] [Full Text] [Related]

  • 14. Thymidylate synthetase levels as a factor in 5-fluorodeoxyuridine and methotrexate cytotoxicity in gastrointestinal tumor cells.
    Washtien WL.
    Mol Pharmacol; 1982 May 01; 21(3):723-8. PubMed ID: 6213845
    [Abstract] [Full Text] [Related]

  • 15. Inactivation of p53 increases the cytotoxicity of camptothecin in human colon HCT116 and breast MCF-7 cancer cells.
    Gupta M, Fan S, Zhan Q, Kohn KW, O'Connor PM, Pommier Y.
    Clin Cancer Res; 1997 Sep 01; 3(9):1653-60. PubMed ID: 9815856
    [Abstract] [Full Text] [Related]

  • 16. Mechanism of action of bisimidazoacridones, new drugs with potent, selective activity against colon cancer.
    Hernandez L, Cholody WM, Hudson EA, Resau JH, Pauly G, Michejda CJ.
    Cancer Res; 1995 Jun 01; 55(11):2338-45. PubMed ID: 7757985
    [Abstract] [Full Text] [Related]

  • 17. Lamin B, caspase-3 activity, and apoptosis induction by a combination of HMG-CoA reductase inhibitor and COX-2 inhibitors: a novel approach in developing effective chemopreventive regimens.
    Swamy MV, Cooma I, Reddy BS, Rao CV.
    Int J Oncol; 2002 Apr 01; 20(4):753-9. PubMed ID: 11894121
    [Abstract] [Full Text] [Related]

  • 18. Selective cytotoxicity of 5-hydroxyuridine for human colon adenocarcinoma cells.
    Lockshin A, Giovanella BC, Mendoza JT, Warneke C, Stehlin JS.
    Cancer Treat Rep; 1985 Apr 01; 69(7-8):845-50. PubMed ID: 3160461
    [Abstract] [Full Text] [Related]

  • 19. Low folate conditions may enhance the interaction of trifluorothymidine with antifolates in colon cancer cells.
    Temmink OH, Hoogeland MF, Fukushima M, Peters GJ.
    Cancer Chemother Pharmacol; 2006 Jan 01; 57(2):171-9. PubMed ID: 16010590
    [Abstract] [Full Text] [Related]

  • 20. Stable differentiation of a human colon adenocarcinoma cell line by sodium butyrate is associated with multidrug resistance.
    Ho SB, Yan PS, Dahiya R, Neuschwander-Tetri BA, Basbaum C, Kim YS.
    J Cell Physiol; 1994 Aug 01; 160(2):213-26. PubMed ID: 7913708
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.